The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Endocrine

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12020-016-0914-9PMID 26965912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic review and meta-analysis.

  2017cited by this paper
• A venous thromboembolism risk assessment model for patients with Cushing’s syndrome

  2016cited by this paper
• Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

  2015cited by this paper
• The Treatment of Cushing's Disease.

  2015cited by this paper
• Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

  2014cited by this paper
• Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?

  2014cited by this paper
• Relationships between 24-hour urinary free cortisol concentrations and metabolic syndrome in obese children.

  2014cited by this paper
• Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome.

  2014cited by this paper
• 24 h urinary free cortisol in large-scale epidemiological studies: short-term and long-term stability and sources of variability.

  2014cited by this paper
• Coronary microvascular function in patients with Cushing’s syndrome

  2013cited by this paper
• Body composition assessment for the definition of cardiometabolic risk

  2013cited by this paper
• High variability in baseline urinary free cortisol values in patients with Cushing’s disease

  2013cited by this paper
• Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome.

  2013cited by this paper
• Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.

  2013cited by this paper
• Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol.

  2013cited by this paper
• Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.

  2012cited by this paper
• Mortality in Cushing's syndrome: a systematic review and meta-analysis.

  2012cited by this paper
• Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome.

  2012cited by this paper
• Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications

  2012cited by this paper
• A 12-month phase 3 study of pasireotide in Cushing's disease.

  2012cited by this paper
• Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure

  2012cited by this paper
• Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

  2011cited by this paper
• An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient:

  2010cited by this paper
• Visceral Adiposity Index

  2010cited by this paper
• Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome.

  2010cited by this paper
• Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome

  2010cited by this paper
• Endothelial dysfunction associated with hypercortisolism is reversible in Cushing's syndrome

  2010cited by this paper
• Role of glucocorticoid receptor polymorphism in adrenal incidentalomas

  2010cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Cushing's disease.

  2009cited by this paper
• Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

  2009cited by this paper
• Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome.

  2009cited by this paper
• Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

  2009cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Cushing's Syndrome.

  2008cited by this paper
• Glucocorticoid measurements in health and disease--metabolic implications and the potential of 24-h urine analyses.

  2008cited by this paper
• Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading.

  2006cited by this paper
• Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission.

  2006cited by this paper
• Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity

  2005cited by this paper
• The metabolic syndrome and cardiovascular risk in Cushing's syndrome.

  2005cited by this paper
• Cushing’s Syndrome

  2005cited by this paper
• Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment.

  2004cited by this paper
• 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.

  2004cited by this paper
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

  2003cited by this paper
• Glucocorticoids and invasive fungal infections.

  2003cited by this paper
• Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.

  2003cited by this paper
• Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.

  2003cited by this paper
• Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol.

  2003cited by this paper
• Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice*

  2001cited by this paper
• Elevated Cortisol Levels in Cushing’s Disease Are Associated With Cognitive Decrements

  2001cited by this paper
• Psychiatric Disorders Associated with Cushing’s Syndrome

  2001cited by this paper
• Cushing's syndrome.

  2001cited by this paper
• Incidence and late prognosis of cushing's syndrome: a population-based study.

  2001cited by this paper
• Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.

  2001cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: 11�-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action*

  2000cited by this paper
• A Clinical Index for Rating Severity in Cushing’s Syndrome

  2000cited by this paper
• Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

  1999cited by this paper
• Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

  1999cited by this paper
• Cushing’s syndrome complicated by multiple opportunistic infections

  1998cited by this paper
• Clinical Correlates of Major Depression in Cushing’s Disease

  1998cited by this paper
• The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

  1997cited by this paper
• Morbidity and mortality in Cushing's disease: an epidemiological approach

  1994cited by this paper
• A population based study

  1993cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• [Treatment of Cushing's disease].

  1978cited by this paper
• An epidemiological approach to road accidents.

  1962cited by this paper

• Consensus on the Diagnosis of Cushing's Disease: A Collaborative Statement from the Korean Endocrine Society and Japan Endocrine Society.

  2026cites this paper
• Unprovoked Deep Vein Thrombosis as a Manifestation of Cushing's Disease

  2026cites this paper
• Consensus on the diagnosis of Cushing’s disease: a collaborative statement from the Korean Endocrine Society and Japan Endocrine Society

  2026cites this paper
• Metabolic, hormonal profiles and comorbidities in pituitary Cushing’s syndrome, adrenal Cushing’s syndrome and mild autonomous cortisol secretion: a comparative study

  2025cites this paper
• Matching-Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing’s Syndrome

  2025cites this paper
• A Second Look at Cushing Disease: Hypercortisolism Recurrence From Another Gland

  2025cites this paper
• Cardiometabolic complications after Cushing’s disease remission

  2025cites this paper
• Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal Incidentalomas

  2024cites this paper
• Whole blood transcriptomic signature of Cushing's syndrome.

  2024cites this paper
• Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre

  2023cites this paper
• Circulating myomiRNAs as biomarkers in patients with Cushing’s syndrome

  2023cites this paper
• Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective

  2023cites this paper
• Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome.

  2022cites this paper
• Pneumocystis pneumonia in patients with Cushing's syndrome: a French multicenter retrospective study.

  2022cites this paper
• Influence of gut microbiota on the development of insulin resistance

  2022cites this paper
• Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation

  2022cites this paper
• Irisin and Secondary Osteoporosis in Humans

  2022cites this paper
• Acute and life-threatening complications in Cushing's syndrome: prevalence, predictors and mortality.

  2021cites this paper
• Medical therapy in severe hypercortisolism.

  2021cites this paper
• Hypercoagulability in Cushing's syndrome: From arterial to venous disease.

  2021cites this paper
• Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome

  2021cites this paper
• Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology.

  2021cites this paper
• Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease

  2020cites this paper
• DMSO_A_249090 1565..1574

  2020cites this paper
• Glucocorticoid excess and COVID-19 disease

  2020cites this paper
• Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis

  2020cites this paper
• Maladie de Cushing dans le département de la Réunion : prévalence, caractéristiques lors du diagnostic, rémissions et récidives après chirurgie transphénoïdale

  2019influential citation
• Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study

  2019cites this paper
• Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study

  2019cites this paper
• Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency

  2019cites this paper
• The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome

  2019cites this paper
• The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”

  2019cites this paper
• Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis

  2019influential citation
• MANAGEMENT OF ENDOCRINE DISEASE: Can we cure Cushing's disease? A personal view.

  2018cites this paper
• Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing’s disease

  2018cites this paper
• Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide

  2018cites this paper
• Are Cushing's disease patients curable?

  2018cites this paper
• Factors predicting long-term comorbidities in patients with Cushing’s syndrome in remission

  2018cites this paper
• Cushing's syndrome: a practical approach to diagnosis and differential diagnoses

  2017cites this paper
• Cushing Disease: Are We Making Progress?

  2017cites this paper
• How useful is urinary-free cortisol in the clinic?

  2017cites this paper